BSETANEJA AEROSPACE & AVIATION LT· Aerospace & DefenseHighNeutral
Announced Wed, 5 Aug, 2026 · 13:12 IST

Q1 FY27 Results - Revenue up 21%, PAT up 62%

Revenue Growth 20pctPat Growth 25pctResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.2%Reaction day
₹297.40
prior close
₹299.50
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.3%+2.9% vs market
Aerospace & Defense peers, median of 25sector+0.2%+4.1% vs sector

On the reaction day the stock moved 2.9 pts more than Nifty Microcap 250 and 4.1 pts more than its Aerospace & Defense peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+6.6
10m
+11.2
15m
+8.5
30m
+8.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.2+1.3+2.9+0.2+4.1
Next day
+8.5+1.6+6.8+1.6+6.8
2d
+5.9+1.7+4.2+1.8+4.1
3d
+5.9+1.6+4.3+1.7+4.2
4d
+4.9+1.5+3.5+1.0+3.9
5d
+5.0+1.8+3.2-0.2+5.2
1w
+4.1+2.1+2.0+0.8+3.2
15d
—+3.2—+3.4—
1m
—+3.7—+1.7—
2m
—+1.1—+1.0—
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Aerospace & Defense peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Taneja Aerospace Q1 FY27 revenue from operations rose 21% YoY to Rs 1,031.30 lakh (vs Rs 852.38 lakh). Total income at Rs 1,154.38 lakh. PAT surged 62% to Rs 573.45 lakh (vs Rs 353.85 lakh). EPS Rs 2.25 vs Rs 1.39. Company also signed a Master Restructuring and Transfer Agreement with Zenith Precision in July 2026 for acquisition of its SEZ Division, subject to approvals.

Likely market impact

Strong YoY revenue and profit growth; pending ZPPL restructuring could reshape business subject to regulatory approvals.